Focused on digital sensor platforms that
detect harmful materials
IdentifySensors is a team of scientists, engineers and business leaders who are building platforms for digital sensor applications intended to disrupt a number of industries. These platforms integrate with the Internet of Things to produce next-generation data and predictive analytics associated with quality, safety and security across a range of industries, including biologics, food safety, infrastructure, environmental monitoring and national security.
Next-Generation Graphene Sensors
IdentifySensors develops novel technologies based on rapidly detecting harmful materials from graphene — a carbon-based film that is the strongest, thinnest and most conductive material known. The company’s patented technology can instantly identify a wide range of dangers, such as viruses and bacteria, foodborne pathogens and explosives.
Co-Founder & CEO
Gregory is serial entrepreneur and level I trauma surgeon, trained at the Cleveland Clinic. He was a medical consultant to NASA and founded two successful healthcare technology companies. Gregory received his M.D. from the Ohio State University and a B.S. in Chemistry and Computer Science from the University of Notre Dame. Greg has deep expertise in the area of clinical diagnosis of infectious disease leveraging bioinformatics and nanotechnologies.
Matthew is a specialist in data science & analytics with applications in diagnostics, supply chain and infrastructure sustainability and security. He held senior management positions at two data technology start-ups including Govini and Bloomberg Government. Matthew is accustomed to leveraging his data science skills in building platforms that generate, process and analyze data for better decision making. Matthew also held senior analyst roles at the U.S. Department of State, BlackRock Financial Management and Merrill Lynch. Matthew received Public Policy and Data Science degrees from Georgetown University and Finance and Economics degrees from Fordham University.
Bruce is an investment banker and founding partner of Hudson Capital Advisors. Starting in 1979 at Drexel Burnham Lambert, he worked on many leveraged buyouts and recapitalizations including Mattel Toys, SFN Co.’s, Magma Copper, Warnaco, Mellon Bank and John Fairfax. Mr. Raben then went on to co-found the Corporate Finance Department at Jefferies & Co. in 1990. At Jeffries, he was the architect of Jeffries entering the Energy and Gaming industries. At CIBC World Markets, he led the bank’s founding investment and financing of Global Crossing.
Rodney has over 30 years of experience in high-technology product design and development in consumer, industrial and regulatory environments. Rodney’s expertise ranges from product concept through development to scaled production. Rodney is a veteran of several start-up technology companies encompassing chip design, artificial intelligence, computer peripherals, information security devices and medical devices. Rodney held senior product management positions at NASA’s Jet Propulsion Lab, Rockwell Semiconductor, Dwyer Instruments and ServiceFlow.
Jeff spent 34 years in the communications industry working in a variety of sales and technical marketing roles. Early sales roles at NCR, Case Communications and Develcon Electronics prepared Jeff for leadership roles at Cisco Systems, a global communications equipment provider. During 26 years at Cisco Systems, Jeff’s leadership assisted Cisco in growing from a domestic business with revenue of $79M (1991) to a global business with nearly $50B of revenue and over 75,000 employees.
Ann is a member of Edward C. Hawkins & Co., Ltd., a CPA firm and a member of Hawkins & Company, LLC., a law firm both of which are based in Cleveland, Ohio. She received her law degree from Marquette University and received her B.B.A with Honors from the University of Notre Dame. Ms. Hawkins is a member of the American Bar Association, Ohio Bar Association, Florida Bar Association, Wisconsin Bar Association and Ohio Society of Certified Public Accountants. She is also admitted to the United States Supreme Court, Supreme Court of the States of Ohio, Wisconsin and Florida.
EVP Regulatory Affairs and Chief Quality Officer
Mr. Kashmolah has more than 30 years of experience in quality and regulatory work leading, developing and transforming global quality in the medical device and biotech industries. Most recently, he was EVP Regulatory Affairs and Chief Quality Officer at Lucira Health where he was responsible for FDA approval and achieved the first multiplex COVID/FLU diagnostic for direct-to-consumer. Prior to Lucira, Mr. Kashmolah led quality and regulatory affairs as Chief Quality Assurance, Regulatory Affairs for Orchid Orthopedic Solutions, SVP of QA/RA for DJO Global, VP of QA/RA at OSI Systems, and VP of Global QA/RA at Life Technologies. At Cardinal Health, Mr. Kashmolah was VP, Global Operations including manufacturing, supply chain, and quality. Mr. Kashmolah holds BS and MS degree in electrical engineering, as well as an Executive MBA. Mr. Kashmolah will play a critical role in FDA and global registration and commercialization for IdentifySensors.
Tommy Sors, Ph.D.
Dr. Sors is Assistant Director of Purdue’s Institute of Inflammation, Immunology and Infectious Disease, where he works to drive strategic direction and manage daily operations of the Institute. Dr. Sors is also involved in the Indiana Clinical and Translational Sciences Institute (CTSI), where he has established a reputation for connecting investigators from across the region to core facilities and research collaborators at Purdue. Dr. Sors received his Ph.D. in Plant Physiology and Molecular Biology from the Department of Horticulture at Purdue University in 2008 and remained at Purdue to complete his post-doctoral research in the Department of Biochemistry.
Rupesh Mishra, Ph.D.
LEad Research Scientist
Dr. Mishra is Lead Research Scientist for IdentifySensors Biologics. Prior experience includes research scientist roles at Purdue University’s School for Biomedical Engineering and the Center for Wearable Sensors at the University of California San Diego (UCSD). Dr. Mishra develops nanosensors for a wide range of applications. He received his Ph.D. in 2013 in the field of biosensors and has authored more than 55 journal articles. Dr. Mishra developed sensor technologies for the U.S. Department of Defense and for Fortune 500 companies. Among Dr. Mishra’s expertise includes nanomaterials, enzymes, biofouling, electroactive materials, aptamers and ink-jet precision printing.
Roger Narayan, Ph.D.
Roger Narayan is a Professor in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University. He is an author of over two hundred publications as well as several book chapters on processing and characterization of biomedical materials. Dr. Narayan has received many honors for his research activities, such as the NCSU Alcoa Foundation Engineering Research Achievement Award, the NCSU Sigma Xi Faculty Research Award and other awards. Dr. Narayan has been elected as Fellow of the American Ceramic Society, AAAS, ASM International, and AIMBE. His research interests include: 2D materials, 3D printing, Biosensors and Drug Delivery.
Navin Pai, Ph.D.
Dr. Pai is a trained molecular biologist, achieving his Ph.D in the field of molecular genetics. His doctoral work is in the field of coagulation with applications such as the identification of thrombosis connected with myeloproliferative neoplasms and antenatal testing for protein C deficiency. His collaborative research employed flow cytometry techniques to detect aberrant cell signaling for diagnosing MDS patients. His previous postdoc tenure was from University of California San Diego (UCSD) nanoengineering department, where he conducted research in photoacoustic imaging to develop efficient point-of-care measurement of heparin levels. Dr. Pai has extensive experience with nucleic acid engineering, DNA synthesis and DNA polymerase.
Koteshwara Reddy, Ph.D.
Dr. Reddy is a trained material scientist, achieving his Ph.D. in the field of Chemistry. His doctoral work focused on biopolymer stabilized metal nanoparticles. Koteshwar was Assistant Professor at the Department of Chemistry at the National Institute of Technology Warangal, Telangana India. Dr. Reddy did postdoctoral research in the Department of Energy Science and Technology at Myongji University, Yongin Republic of Korea focusing on material synthesis of carbon nanomaterials, bimetallic chalcogenides, molecular imprinted polymers, hybrid nanocomposites for electrochemical biosensors, energy, photo/electrocatalytic, corrosion and biomedical applications.
Dr. Richard Kuhn
Dr. Kuhn is Director of the Purdue Institute of Inflammation, Immunology, and Infectious Disease. His research has focused on the replication and assembly of the alphaviruses and the flaviviruses. Dr. Kuhn has been involved in many fundamental studies examining the structure and assembly of enveloped viruses, including the first structure of dengue virus. His focus continues to be in virus replication, virion assembly, pathogenesis, and host cell interactions using biochemical, genetic, and structural techniques. In 2007 he was elected a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Science. He was an American Society for Microbiology lecturer. He is the chair of the U.S. Panel on Viral Diseases of the US-Japan Cooperative Medical Sciences Program at NIAID.
Steve is President of Barrett Advisory, a strategic and operational consulting firm involved with Whole Health Management, Thomas H. Lee Partners, SAP America, Green Visions, Healthspot and Endotronix. Prior to launching his own advisory firm, Steve was Executive Vice President and Chief Financial Officer of Whirlpool Corporation and Chief Financial Officer of Global Fabric & Home Care at the Procter & Gamble Company, where he spent most of his career before retiring in 2002. Steve has an MBA in finance from Boston College and BS, Pre-Professional/Chemistry from the University of Notre Dame.
Consumer Goods & Marketing
Dick is an independent consultant to private equity firms on acquisition and merger deals. Dick’s most recent engagements include working with GTCR, Madison Dearborn, BC Partners, KKR and Goldman Sachs. Prior to launching his own advisory firm, Dick was Chairman and CEO of Catalina Marketing Corp., a global marketing firm that was sold to private equity firm Hellman & Friedman for $1.7 billion. Dick also served as CEO and Chairman of Willis Stein & Partners, a private equity firm focused on the consumer packaged goods space. Mr. Buell was also President and COO of Foodbrands America, which was sold to Tyson Foods in 2001. Earlier in his career Dick was President and CEO of Griffith Laboratories and Vice President of Marketing for Kraft Foods Company. Dick has served on many boards including: American Society of Mechanical Engineers, SC Johnson, Prestige Brands, University of Chicago’s Graduate School of Marketing and Purdue University’s Marketing Advisory Council.
Senior Executive Business Strategist
Steve is accomplished C-level executive with more than 30 years of entrepreneurial experience in starting, growing, developing, and turning-around multimillion-dollar companies in highly competitive markets. Steve’s work experience includes leadership positions at Lotus, Avid Technology, PictureTel, e-studio Live, Sentito Networks and Akamai Technologies.